Expectant management with selective delayed intervention for favorable risk prostate cancer

Laurence Klotz1
1University of Toronto, Division of Urology, Sunnybrook & Women's College Health Sciences Centre, 2075 Bayview Avenue MG 408, Toronto, Ontario M4N 3M5, Canada

Tài liệu tham khảo

Johansson, 1992, High 10 year survival rate in patients with early, untreated prostatic cancer, JAMA, 267, 2191, 10.1001/jama.267.16.2191

Johansson, 1997, Johansson S, Bergstrom R, Adami HO. Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden, JAMA, 277, 467, 10.1001/jama.277.6.467

Hanash, 1972, Carcinoma of the prostate, J Urol, 107, 450, 10.1016/S0022-5347(17)61053-X

Cook, 1968, Twenty nodules of prostate cancer not treated by total prostatecotmy, J Urol, 100, 672, 10.1016/S0022-5347(17)62595-3

Lerner, 1991, The risk of dying of prostate cancer in patients with clinically localized disease, J Urol, 146, 1040, 10.1016/S0022-5347(17)37997-1

Handley, 1988, Deferred treatment for prostate cancer, Br I Urol, 62, 249, 10.1111/j.1464-410X.1988.tb04328.x

Adolfsson, 1992, Deferred treatment in clinically localized prostate carcinoma, Br J Urol, 69, 183, 10.1111/j.1464-410X.1992.tb15493.x

Waaler, 1993, Prognosis of localised prostatic cancer managed by “Watch and Wait” policy, Br J Urol, 72, 214, 10.1111/j.1464-410X.1993.tb00690.x

Whitmore, 1991, Expectant management of localized prostatic cancer, Cancer, 67, 1091, 10.1002/1097-0142(19910215)67:4<1091::AID-CNCR2820670437>3.0.CO;2-J

George, 1988, Natural history of localised prostatic cancer managed by conservative therapy alone, Lancet, 1, 494, 10.1016/S0140-6736(88)91294-9

Aus, 1995, Long-term survival and mortality in prostate cancer treated with noncurative intent, J Urol, 154, 460, 10.1016/S0022-5347(01)67074-5

Albertsen, 1998, Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer, JAMA, 280, 975, 10.1001/jama.280.11.975

Albertsen PC. Prostate cancer mortality trends in Oregon and Connecticut. Presented at the Whistler International Conference on Prostate Cancer, March 2001.

Chodak, 1994, Conservative Management of Localized Prostate Cancer, NEJU, 330, 242, 10.1056/NEJM199401273300403

Sakr, 1993, The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients, J Urol, 150, 379, 10.1016/S0022-5347(17)35487-3

Pound, 1999, Natural history of progression after PSA elevation following radical prostatectomy, JAMA, 281, 1591, 10.1001/jama.281.17.1591

Kattan, 2000, Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer, J Clin Oncol, 18, 3352, 10.1200/JCO.2000.18.19.3352

Zietman, 2001, Conservative management of prostate cancer in the prostate specific antigen era, J Urol, 166, 1702, 10.1016/S0022-5347(05)65657-1